314 related articles for article (PubMed ID: 28168662)
1. Multicentric Castleman's disease associated with IgA vasculitis (Henoch-Schönlein purpura) responding well to tocilizumab: a case report.
Oshima Y; Hoshino J; Suwabe T; Hayami N; Yamanouchi M; Sekine A; Ueno T; Mizuno H; Yabuuchi J; Imafuku A; Kawada M; Hiramatsu R; Hasegawa E; Sawa N; Takaichi K; Hayashi N; Fujii T; Ubara Y
Clin Rheumatol; 2017 Mar; 36(3):729-733. PubMed ID: 28168662
[TBL] [Abstract][Full Text] [Related]
2. Membranous nephropathy associated with multicentric Castleman's disease that was successfully treated with tocilizumab: a case report and review of the literature.
Saiki R; Katayama K; Hirabayashi Y; Oda K; Fujimoto M; Murata T; Nakajima A; Dohi K
BMC Nephrol; 2021 Jun; 22(1):216. PubMed ID: 34107915
[TBL] [Abstract][Full Text] [Related]
3. Henoch-Schönlein purpura: clinicopathologic correlation of cutaneous vascular IgA deposits and the relationship to leukocytoclastic vasculitis.
Helander SD; De Castro FR; Gibson LE
Acta Derm Venereol; 1995 Mar; 75(2):125-9. PubMed ID: 7604640
[TBL] [Abstract][Full Text] [Related]
4. Schönlein-Henoch purpura during pregnancy with successful outcome for mother and newborn.
Feldmann R; Rieger W; Sator PG; Gschnait F; Breier F
BMC Dermatol; 2002; 2():1. PubMed ID: 11866865
[TBL] [Abstract][Full Text] [Related]
5. Clostridioides difficile infection in a patient with immunoglobulin A vasculitis: a triggering factor or a rare complication of the disease? A case-based review.
Kounatidis D; Vadiaka M; Kouvidou C; Sampaziotis D; Skourtis A; Panagopoulos F; Konstantinou F; Vallianou NG
Rheumatol Int; 2020 Jun; 40(6):997-1000. PubMed ID: 32318801
[TBL] [Abstract][Full Text] [Related]
6. A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and Future.
Parums DV
Med Sci Monit; 2024 Jan; 30():e943912. PubMed ID: 38281080
[TBL] [Abstract][Full Text] [Related]
7. Henoch-Schönlein purpura in an older man presenting as rectal bleeding and IgA mesangioproliferative glomerulonephritis: a case report.
Cheungpasitporn W; Jirajariyavej T; Howarth CB; Rosen RM
J Med Case Rep; 2011 Aug; 5():364. PubMed ID: 21831272
[TBL] [Abstract][Full Text] [Related]
8. Hemorrhagic bullous IgA vasculitis (Schönlein-Henoch purpura), does it have a worse prognosis?
Alonso de la Hoz J; Martínez Antequera CE; Fernández Manso B; Llorente Otones L; de Inocencio Arocena J
Reumatol Clin (Engl Ed); 2021 Nov; 17(9):549-551. PubMed ID: 34756318
[TBL] [Abstract][Full Text] [Related]
9. Anti-interleukin-6 receptor antibody (tocilizumab) treatment of multicentric Castleman's disease.
Matsuyama M; Suzuki T; Tsuboi H; Ito S; Mamura M; Goto D; Matsumoto I; Tsutsumi A; Sumida T
Intern Med; 2007; 46(11):771-4. PubMed ID: 17541233
[TBL] [Abstract][Full Text] [Related]
10. A comorbid case of multicentric Castleman's disease and pulmonary hyalinising granuloma successfully treated with tocilizumab and corticosteroid.
Takeuchi N; Arai T; Kitaichi M; Inoue Y
BMJ Case Rep; 2013 Sep; 2013():. PubMed ID: 24072826
[TBL] [Abstract][Full Text] [Related]
11. Henoch-Schönlein Purpura (IgA Vasculitis) in Association with Thyrotoxicosis.
Sanjari M; Shakibi M; Safavi M
Case Rep Endocrinol; 2021; 2021():6669653. PubMed ID: 34123438
[TBL] [Abstract][Full Text] [Related]
12. Henoch-Schonlein purpura in mesothelioma.
Joshi S; Pillai S; Chakera A; Lee YC
Respirol Case Rep; 2014 Dec; 2(4):138-40. PubMed ID: 25530863
[TBL] [Abstract][Full Text] [Related]
13. A case of tocilizumab-refractory idiopathic multicentric Castleman's disease successfully treated with sirolimus.
Sumiyoshi R; Koga T; Furukawa K; Umeda M; Yamamoto K; Mori R; Kawakami A
Clin Immunol; 2021 Dec; 233():108887. PubMed ID: 34798240
[TBL] [Abstract][Full Text] [Related]
14. Coronavirus disease 2019-associated immunoglobulin A vasculitis/Henoch-Schönlein purpura: A case report and review.
Jedlowski PM; Jedlowski MF
J Dermatol; 2022 Jan; 49(1):190-196. PubMed ID: 34741345
[TBL] [Abstract][Full Text] [Related]
15. Severe hemorrhagic bullous lesions in Henoch Schonlein purpura: three pediatric cases and review of the literature.
Trapani S; Mariotti P; Resti M; Nappini L; de Martino M; Falcini F
Rheumatol Int; 2010 Aug; 30(10):1355-9. PubMed ID: 19609528
[TBL] [Abstract][Full Text] [Related]
16. Rare case of ankylosing spondylitis complicated by IgA vasculitis.
Kamath S; Ahmed T; Rana F; Upadhyay AS
BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36423941
[TBL] [Abstract][Full Text] [Related]
17. [Compartment syndrome: an atypical presentation as a cause of Henoch-Schönlein purpura].
Botero-Bermúdez M; Briceño-Rodríguez L; Quiñonez-Yepes T; Taborda-Aitken JC
Acta Ortop Mex; 2022; 36(5):324-328. PubMed ID: 37402500
[TBL] [Abstract][Full Text] [Related]
18. Recurrent Henoch Schönlein purpura without renal involvement successfully treated with methotrexate.
Miray Kisla Ekinci R; Balci S; Serbes M; Duyuler Ayçin G; Dogruel D; Ufuk Altintas D; Yilmaz M
Scott Med J; 2019 May; 64(2):74-77. PubMed ID: 30453828
[TBL] [Abstract][Full Text] [Related]
19. [Schönlein-Henoch purpura - single-center, retrospective analysis of the diagnostic process, treatment and course in adults].
Konieczniak K; Rekowski FW; Gładyś A; Zugajb P; Rymarz A; Niemczyk S
Pol Merkur Lekarski; 2021 Apr; 49(290):99-102. PubMed ID: 33895753
[TBL] [Abstract][Full Text] [Related]
20. Circulating IgA producing cells in the differential diagnosis of Henoch-Schönlein purpura.
Casanueva B; Rodriguez-Valverde V; Luceño A
J Rheumatol; 1988 Aug; 15(8):1229-33. PubMed ID: 3184070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
